Ascend Laboratories, LLC

Frequent Recalls

9

Recalls

0

Units Recalled

0

Injuries

0

Deaths

Categories: Drug

2026-05-20 to 2026-08-05

Date	Source	Product	Brand	Severity	Units
2026-08-05	FDA Drug	FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx	Ascend Laboratories, LLC	Class III	N/A
2026-08-05	FDA Drug	FDA Recall: Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx	Ascend Laboratories, LLC	Class III	N/A
2026-08-05	FDA Drug	FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx o	Ascend Laboratories, LLC	Class III	N/A
2026-07-29	FDA Drug	FDA Recall: Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactur	Ascend Laboratories, LLC	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Labor	Ascend Laboratories, LLC	Class III	N/A
2026-07-29	FDA Drug	FDA Recall: Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Labor	Ascend Laboratories, LLC	Class III	N/A
2026-06-17	FDA Drug	FDA Recall: Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactu	Ascend Laboratories, LLC	Class II	N/A
2026-06-10	FDA Drug	FDA Recall: Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Al	Ascend Laboratories, LLC	Class II	N/A
2026-05-20	FDA Drug	FDA Recall: Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufa	Ascend Laboratories, LLC	Class II	N/A

Ascend Laboratories, LLC Recalls | WatchRecall